Market Cap | 329.19M | P/E | - | EPS this Y | -7.90% | Ern Qtrly Grth | - |
Income | -184.35M | Forward P/E | -55.93 | EPS next Y | 73.20% | 50D Avg Chg | -15.00% |
Sales | 303.91M | PEG | -1.22 | EPS past 5Y | -42.23% | 200D Avg Chg | -28.00% |
Dividend | N/A | Price/Book | 0.88 | EPS next 5Y | 15.00% | 52W High Chg | -66.00% |
Recommedations | 1.70 | Quick Ratio | 1.38 | Shares Outstanding | 40.63M | 52W Low Chg | 3.00% |
Insider Own | 5.42% | ROA | -5.82% | Shares Float | 39.02M | Beta | 0.65 |
Inst Own | 81.82% | ROE | -63.15% | Shares Shorted/Prior | 1.25M/1.39M | Price | 8.39 |
Gross Margin | 50.90% | Profit Margin | -60.66% | Avg. Volume | 370,435 | Target Price | 13.33 |
Oper. Margin | -12.21% | Earnings Date | Oct 3 | Volume | 252,090 | Change | -2.44% |
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
HC Wainwright & Co. | Buy | Sep 20, 24 |
Canaccord Genuity | Buy | Jul 17, 24 |
HC Wainwright & Co. | Buy | Jul 17, 24 |
HC Wainwright & Co. | Buy | May 22, 24 |
Oppenheimer | Outperform | Apr 5, 24 |
Raymond James | Outperform | Jan 9, 24 |
HC Wainwright & Co. | Buy | Jan 8, 24 |
Raymond James | Outperform | Oct 6, 23 |
Canaccord Genuity | Buy | Oct 5, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Helsel Dave | SVP Global Operation.. SVP Global Operations and R&D | Apr 28 | Sell | 22.44 | 3,513 | 78,832 | 22,874 | 05/02/22 |
DONNELLY HOWARD W | Director Director | Apr 20 | Option | 15.95 | 6,022 | 96,051 | 104,734 | 04/21/22 |
JOHNSON WESLEY | Director Director | Apr 11 | Sell | 23.13 | 7,500 | 173,475 | 79,704 | 04/13/22 |
Trowbridge Stephen A | EVP and CFO EVP and CFO | Jan 12 | Buy | 22.64 | 1,000 | 22,640 | 76,081 | 01/12/22 |
Clemmer James C | President and CEO President and CEO | Jan 11 | Buy | 22.84 | 10,000 | 228,400 | 390,764 | 01/12/22 |
Centea Scott | Sr. VP/GM, Global VI.. Sr. VP/GM, Global VIT | Oct 15 | Option | 16.77 | 12,000 | 201,240 | 58,244 | 10/18/21 |
Centea Scott | Sr. VP/GM, Global VI.. Sr. VP/GM, Global VIT | Oct 15 | Sell | 27.92 | 12,000 | 335,040 | 46,244 | 10/18/21 |
Meteny Dennis S | Director Director | Jul 30 | Option | 14.64 | 5,726 | 83,829 | 117,865 | 07/30/21 |
Trowbridge Stephen A | EVP and CFO EVP and CFO | Apr 16 | Option | 14.07 | 13,625 | 191,704 | 73,371 | 04/16/21 |
DONNELLY HOWARD W | Director Director | Apr 05 | Option | 14.64 | 5,726 | 83,829 | 96,595 | 04/05/21 |